IMPROVING ONCOLOGY ANALYSIS WITH INTEGRATED KRAS ASSAY SERVICES AND RAS ASSAYS

within the swiftly evolving industry of oncology investigate, correct and efficient mutation screening is essential for developing targeted therapies. The KRAS Services System performs a pivotal job Within this landscape by featuring complete alternatives for KRAS mutation profiling and Assessment. KRAS mutations, present in roughly ninety five% of